IP Library Granted Patent US 10,420,459
Granted Patent B2
US 10,420,459 · App. 15/798,072 · Granted Sep 24, 2019

Method of performing a sphenopalatine ganglion block procedure

Inventors: Stephen W. Chandler (Montgomery, AL); David W. Sanso (Morrison, CO)
Assignee: BioVision Technologies, LLC
A61B1/0684A61B1/00135A61B1/015A61B1/06A61B1/0623A61B17/24A61M25/10A61M25/10182A61M31/00A61M25/1002A61M25/1011A61M2025/105A61M2025/1052A61M2202/048A61M2210/06A61M2210/0618A61M2210/0681
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,420,459
App. No.
15/798,072
Granted
Sep 24, 2019
Kind
B2
Abstract

Methods and devices to quickly and accurately locate the sphenopalatine ganglion (SPG) while performing a sphenopalatine ganglion block procedure that introduces a medication to the SPG. The methods and devices also prevent the medication applied to the SPG from flowing down a patient's throat during the procedure.

Claims (37)

1. A method for delivering a medication to a sphenopalatine ganglion of a patient, the method comprising the steps of:

(a) inserting a portion of a device through a nostril of the patient, the device comprising:

a handle comprising a proximal end and a distal end and an inflation device;

a flexible tubular member extending from the handle, the flexible tubular member comprising a proximal end, a distal end, an inflation lumen coupled to the inflation device and extending from the proximal end of the flexible tubular member, and a second lumen extending from the proximal end of the flexible tubular member to a port;

an expandable member attached to the flexible tubular member, wherein the inflation lumen is coupled to an inflation port disposed within the expandable member, wherein the medication port is disposed proximally of the expandable member; and

an illumination device affixed to the flexible tubular member and disposed distally of the expandable member;

(b) viewing light emitted from the illumination device through a portion of the patient's palate;

(c) expanding, using the inflation device, the expandable member adjacent to the patient's choana; and

(d) delivering an amount of medication through the port, such that the medication contacts at least a portion of mucosa overlaying the sphenopalatine ganglion of the patient for a period of at least 5 minutes.

2. The method of claim 1 , further comprising the step of removing the portion of the device through the nostril of the patient.

3. The method of claim 2 , further comprising the step of inserting the portion of the device through a second nostril of the patient and performing steps (b) through (d).

4. The method of claim 3 , further comprising the step of removing the portion of the device through the second nostril of the patient.

5. The method of claim 1 , further comprising the step of at least partially collapsing the expandable member.

6. The method of claim 1 , wherein the level of medication is maintained for 10 minutes to 30 minutes.

7. The method of claim 6 , wherein the level of medication is maintained for 15 minutes to 25 minutes.

8. The method of claim 1 , wherein the level of medication is maintained for at least 10 minutes.

9. The method of claim 8 , wherein the level of medication is maintained for at least 15 minutes.

10. The method of claim 9 , wherein the level of medication is maintained for at least 20 minutes.

11. The method of claim 10 , wherein the level of medication is maintained for at least 25 minutes.

12. The method of claim 1 , wherein the step of inserting the portion the device through the nostril comprises introducing the portion of the device into or through a nasal cavity and into a channel below an inferior turbinate and above a hard palate.

13. The method of claim 12 , wherein the step of expanding the expandable member adjacent to the patient's choana comprises placing the expandable member in the patient's nasopharynx.

14. The method of claim 1 , wherein the inflation device comprises a plunger, wherein a portion of the plunger is in the handle and a portion of the plunger extends from the distal end of the handle.

15. A method for delivering a medication to a sphenopalatine ganglion of a patient, the method comprising the steps of:

(a) inserting a portion of a device through a nostril of the patient, the device comprising:

a handle comprising a proximal end and a distal end;

an inflation device integrated in the handle, wherein the inflation device comprises a plunger extending from the distal end of the handle;

a flexible tubular member extending from the handle, the flexible tubular member comprising a proximal end, a distal end, an inflation lumen coupled to the inflation device and extending from the proximal end of the flexible tubular member, and a second lumen extending from the proximal end of the flexible tubular member to a port;

an expandable member attached to the flexible tubular member, wherein the inflation lumen is coupled to an inflation port disposed within the expandable member, wherein the medication port is disposed proximally of the expandable member; and

an illumination device affixed to the flexible tubular member distally of the expandable member;

(b) viewing light emitted from the illumination device through a portion of the patient's palate;

(c) expanding, using the inflation device, the expandable member adjacent to the patient's choana; and

(d) delivering an amount of medication through the port, such that the medication contacts at least a portion of mucosa overlaying the sphenopalatine ganglion of the patient for a period of at least 5 minutes.

16. The method of claim 15 , further comprising the step of removing the portion of the device through the nostril of the patient.

17. The method of claim 16 , further comprising the step of inserting the portion of the device through a second nostril of the patient and performing steps (b) through (d).

18. The method of claim 15 , wherein the level of medication is maintained for at least 5 minutes.

19. The method of claim 15 , wherein the step of inserting the portion the device through the nostril comprises introducing the portion of the device into or through a nasal cavity and into a channel below an inferior turbinate and above a hard palate.

20. The method of claim 19 , wherein the step of expanding the expandable member adjacent to the patient's choana comprises placing the expandable member in the patient's nasopharynx.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 20, 2025
From: BIOVISION TECHNOLOGIES LLC
To: BIOVISION HOLDINGS LLC
Reel/Frame 071171/0030 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2024
From: CHANDLER, STEPHEN
To: VALENT MEDICAL, INC.
Reel/Frame 068796/0831 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2024
From: SANSO, DAVID
To: VALENT MEDICAL, INC.
Reel/Frame 068797/0028 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2024
From: BIOVISION HOLDINGS, LLC
To: VALENT MEDICAL, INC.
Reel/Frame 068799/0583 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2019
From: CHANDLER, STEPHEN W.; SANSO, DAVID W.
To: BIOVISION TECHNOLOGIES, LLC
Reel/Frame 050042/0186 →
Continuity (7)
Continuation 15008115 · Jan 27, 2016
Continuation 14712722 · May 14, 2015
Continuation 14699999 · Apr 29, 2015
Continuation In Part 14572353 · Dec 16, 2014
Continuation In Part 14298521 · Jun 6, 2014
Provisional Application 61917097 · Dec 17, 2013
Related Publication 20180042471A1 · Feb 15, 2018